MoneyWorks4Me

Sandu Pharmaceuticals informs about certificate

08 Apr 2022 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018, Sandu Pharmaceuticals has forwarded a copy of certificate received by them from Link Intime India, the Registrar and Share Transfer Agents of the Company for the Quarter ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1738.10
Dr. Reddys Labs. 1228.35
Cipla 1304.85
Lupin 1912.85
Zydus Lifesciences 1108.15
View more..